|
|
|
|
| LEADER |
01819nam 2200457 i 4500 |
| 001 |
ZAG01000556780 |
| 003 |
HR-ZaZAG |
| 005 |
20130219115016.0 |
| 008 |
081220s2003 ci a 000 0 hrv d |
| 035 |
|
|
|a (HR-ZaZAG)000556780
|
| 040 |
|
|
|a HR-ZaMFS
|b hrv
|c HR-ZaMFS
|e ppiak
|
| 041 |
0 |
|
|a hrv
|
| 044 |
|
|
|a ci
|
| 060 |
1 |
4 |
|a WJ 342
|
| 100 |
1 |
|
|a Kovač, Biserka
|
| 245 |
1 |
0 |
|a Kliničko i neurofiziološko praćenje bolesnika na dijalizi s uremijskom polineuropatijom i anemijom te utjecaj terapije eritropoetinom :
|b magistarski rad /
|c Biserka Kovač.
|
| 260 |
|
|
|a Zagreb :
|b [s.n.] ,
|c 2003.
|
| 300 |
|
|
|a 109 str. :
|b graf. prikazi ;
|c 30 cm.
|
| 500 |
|
|
|a Tečaj: Klinička neurologija
|
| 502 |
|
|
|a Mag. rad, Med. fak. Zagreb, 2003
|
| 504 |
|
|
|a Sažetak ; Summary: Clinical and neurophysiological observation of dialysis patients with uremic polyneuropathy and anemia, and the influence of the erythropoietin therapy
|
| 504 |
|
|
|a Bibliografija: str. 99-106
|
| 650 |
|
2 |
|a Bubrežna insuficijencija, kronična
|
| 650 |
|
2 |
|a komplikacije
|
| 650 |
|
2 |
|a Eritropoetin, rekombinantni -
|x terapijska primjena
|
| 650 |
|
2 |
|a Hemodijaliza -
|x metode
|
| 650 |
|
2 |
|a Polineuropatije -
|x etiologija
|
| 650 |
|
2 |
|a Polineuropatije -
|x farmakoterapija
|
| 650 |
|
2 |
|a Amemia -
|x drug therapy
|
| 650 |
|
2 |
|a Erythropoietin, Recombinant -
|x therapeutic use
|
| 650 |
|
2 |
|a Kidney Failure, Chronic -
|x complications
|
| 650 |
|
2 |
|a Polyneuropathies -
|x etiology
|
| 650 |
|
2 |
|a Polyneuropathies -
|x drug therapy
|
| 650 |
|
2 |
|a Renal Dialysis -
|x methods
|
| 650 |
|
2 |
|a Anemija -
|x farmakoterapija
|
| 945 |
1 |
|
|a Marija Šoštarko
|b 07.11.2003.
|c 3333
|
| 946 |
1 |
|
|a Petar Kes, Marija Šoštarko, Marija žagar
|b Petar Kes, Marija Šoštarko, Marija žagar
|
| OWN |
|
|
|a MFSNZ
|
| 852 |
|
|
|a MFS
|